Limited Access to Prescription Medications (Resolution No. 99-3-03)

May 8, 2003 2:46 PM Topics: Resolutions

Resolution No. 99-3-03
Title: Limited Access to Prescription Medications

Whereas, NABP recognizes the importance of all US citizens having access to medications; and

Whereas, access is sometimes limited by manufacturers through limited distribution policies; and

Whereas, limited access programs and policies can place patients at risk from beginning, continuing, or completing their medication therapy;

THEREFORE BE IT RESOLVED that the NABP Executive Committee in collaboration with the Food and Drug Administration (FDA) and the Pharmaceutical Research and Manufacturers of America (PhRMA) commission a task force to study the public health consequences of restricted access policies and programs.

(Resolution passed at NABP’s 99th Annual Meeting, Philadelphia, PA)